Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Co-Diagnostics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 2 | 71 | −9 |
| Shares | 6.93M | 352.6K | 7.23M | +658.1K (+10.0%) |
| Value | $42.7M | $2.18M | $40.9M | +$385.9K (+1.0%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Globeflex Capital L P | 220,479 | $1.24M | 0.30% |
| Bank of Montreal | 62,410 | $349.0K | 0.00% |
| Occudo Quantitative Strategies LP | 32,032 | $180.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 30,700 | $172.0K | 0.00% |
| XTX Topco Ltd | 25,305 | $142.0K | 0.06% |
| Raymond James & Associates | 18,923 | $106.0K | 0.00% |
| Strategic Asset Management, LLC | 1,000 | $6.00K | 0.01% |
| Rockefeller Capital Management L.P. | 400 | $2.00K | 0.00% |
| National Bank of Canada | 200 | $1.00K | 0.00% |
| Harbour Investments, Inc. | 10 | $0 | 0.00% |
Sold out (19)
Institutions that held Co-Diagnostics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Engineers Gate Manager LP | 122,003 | $754.0K |
| Jane Street Group, LLC | 77,748 | $480.0K |
| Principal Financial Group Inc | 49,652 | $307.0K |
| 683 Capital Management, LLC | 37,000 | $229.0K |
| Trexquant Investment LP | 26,576 | $164.0K |
| AXS Investments LLC | 24,980 | $154.0K |
| Paloma Partners Management Co | 18,843 | $116.0K |
| Prelude Capital Management, LLC | 17,200 | $106.0K |
| LPL Financial LLC | 14,050 | $87.0K |
| ExodusPoint Capital Management, LP | 13,298 | $82.0K |
| Tower Research Capital LLC (TRC) | 7,919 | $49.0K |
| Quantbot Technologies LP | 7,551 | $46.0K |
| Simplex Trading, LLC | 4,757 | $29.0K |
| Prospera Financial Services Inc | 2,550 | $16.0K |
| UBS Group AG | 1,500 | $9.00K |
| American Portfolios Advisors | 1,300 | $8.03K |
| Creative Financial Designs Inc | 200 | $1.00K |
| Focused Wealth Management, Inc | 100 | $1.00K |
| Bogart Wealth, LLC | 100 | $1.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Co-Diagnostics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 331,410 | $2.05M |
| Susquehanna Fundamental Investments, LLC | 21,215 | $131.0K |